Ber-EP4 staining in effusion cytology: A potential source of false positives
- 18 July 2020
- journal article
- review article
- Published by Elsevier BV in Revista Española de Patología
- Vol. 54 (2), 114-122
- https://doi.org/10.1016/j.patol.2020.04.005
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Utility of a limited panel of calretinin and Ber-EP4 immunocytochemistry on cytospin preparation of serous effusions: A cost-effective measure in resource-limited settingsCytojournal, 2011
- Utility of paired box gene 8 (PAX8) expression in fluid and fine‐needle aspiration cytologyCancer Cytopathology, 2010
- The high post-test probability of a cytological examination renders further investigations to establish a diagnosis of epithelial malignant pleural mesothelioma redundantDiagnostic Cytopathology, 2006
- The mesothelial cellThe International Journal of Biochemistry & Cell Biology, 2004
- Immunohistochemical Diagnosis of Papillary Thyroid CarcinomaLaboratory Investigation, 2001
- Monoclonal antibody Ber‐EP4: Its use in the differential diagnosis of malignant mesothelioma and carcinoma in cell blocks of malignant effusions and FNA specimensDiagnostic Cytopathology, 1994
- Utility of BER‐EP4 in the diagnosis of adenocarcinoma in effusions: An immunocytochemical study of 232 casesDiagnostic Cytopathology, 1993
- Identification of Malignant Cells In Serous Effusions Using A Panel of Monoclonal Antibodies Ber-Ep4, Mca-B-12 and EmaCytopathology, 1992
- The utility of ancillary techniques in effusion cytologyDiagnostic Cytopathology, 1992
- Malignant effusionsCA: A Cancer Journal for Clinicians, 1991